Jason Bell
Foot & Ankle Surgery · Newark, DENPI 1275528309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Smith+Nephew at 37.0% of the total. Reporting peaked in 2023 at $919 and has fallen 56.4% since, to $400 in 2025.
Across 173 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Organogenesis Inc.$946
- Stryker$461
- Averitas Pharma Inc.$209
- Vaporox, Inc.$103
- Kerecis Limited$78
- plus $779 from 23 others
What the payments were for
- Food & beverage$4,065100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 63 | $1,510 |
| Organogenesis Inc. | 43 | $946 |
| Stryker(2 entities) | 12 | $461 |
| Averitas Pharma Inc. | 10 | $209 |
| Vaporox, Inc. | 1 | $103 |
| Kerecis Limited | 3 | $78 |
| Nevro Corp. | 4 | $74 |
| Acumed LLC | 2 | $69 |
| GRT US Holding, Inc. | 4 | $57 |
| Paratek Pharmaceuticals, Inc. | 3 | $56 |
| AbbVie | 3 | $54 |
| Integra Lifesciences Corporation | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Bioventus LLC | 2 | $42 |
| KCI USA, Inc. | 2 | $40 |
| Zimmer Biomet | 1 | $38 |
| Osteomed LLC | 2 | $37 |
| Abbott | 2 | $33 |
| Johnson & Johnson | 1 | $32 |
| IBSA Pharma Inc. | 1 | $25 |
| Osiris Therapeutics Inc. | 1 | $19 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $16 |
| Acera Surgical, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Convatec Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,085 in reported general payments places this provider in the 60th percentile of 32 foot & ankle surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 23 | $285 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $112 |
| Cephalexin | 11 | $72 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Newark
- Kirstyn UrbasNewark$7K
- Raymond di PretoroNewark$4K
- Aabha SuchakNewark$2K
- Anthony CaristoNewark$1K
- Arij RashidNewark$242
- William NewcombNewark$23
- Jacob HanlonDover$50K
- Cody BowersWilmington$14K
- Brendan KaneLewes$11K
- Bradley LemonSeaford$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.